Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$51.22 - $60.16 $4.99 Million - $5.87 Million
97,500 New
97,500 $5.15 Million
Q4 2023

Feb 09, 2024

BUY
$26.88 - $83.49 $806,400 - $2.5 Million
30,000 New
30,000 $2.5 Million
Q2 2023

Aug 10, 2023

SELL
$32.62 - $40.75 $959,027 - $1.2 Million
-29,400 Reduced 34.83%
55,000 $1.79 Million
Q1 2023

May 11, 2023

BUY
$33.36 - $45.71 $1.81 Million - $2.49 Million
54,400 Added 181.33%
84,400 $2.97 Million
Q4 2022

Feb 09, 2023

BUY
$35.77 - $51.11 $1.07 Million - $1.53 Million
30,000 New
30,000 $1.37 Million
Q2 2022

Aug 10, 2022

BUY
$33.93 - $48.92 $678,600 - $978,400
20,000 New
20,000 $786,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.62B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.